GS

Gerrit Steen

Director Director DIN 02285739
DIN 02285739 First appointment Aug 2008 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2008
Shareholding value Locked Premium profile

About Gerrit Steen

Data last updated:

Gerrit Steen has 18 years in corporate governance. Formerly with 1 company, such as Fresenius Kabi Oncology Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02285739
Primary Designation Director
First Appointment 11 Aug 2008
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Fresenius Kabi Oncology Limited U24231DL2003PLC119441
Director11 Aug 20082003Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Fresenius Kabi Oncology Limited
Premium access

Shareholding and investment profile for Gerrit Steen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gerrit Steen

Gerrit Steen has 18 years in corporate governance. Formerly with 1 company, such as Fresenius Kabi Oncology Limited. Engaged in General Business. Contributes to corporate operations.

Gerrit Steen is associated with 0 companies as a director.

Gerrit Steen has expertise in General Business.

Gerrit Steen has 18 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available